Chemistry:BMAPN

From HandWiki
Short description: Substituted cathinone stimulant drug
BMAPN
Bk-methamnetamine.svg
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC14H15NO
Molar mass213.280 g·mol−1
3D model (JSmol)

BMAPN (βk-methamnetamine) is a substituted cathinone derivative with stimulant effects. It inhibits dopamine reuptake and has rewarding and reinforcing properties in animal studies.[1][2] It is banned under drug analogue legislation in a number of jurisdictions. The drug was at one point marketed under the name NRG-3, although only a minority of samples of substances sold under this name have been found to actually contain BMAPN, with most such samples containing mixtures of other cathinone derivatives.[3][4]

See also

References

  1. "A novel synthetic cathinone, 2-(methylamino)-1-(naphthalen-2-yl) propan-1-one (BMAPN), produced rewarding effects and altered striatal dopamine-related gene expression in mice". Behavioural Brain Research 317: 494–501. January 2017. doi:10.1016/j.bbr.2016.10.016. PMID 27737791. 
  2. "Behavioral Profiles and Underlying Transmitters/Circuits of Cathinone-Derived Psychostimulant Drugs of Abuse.". Synthetic Cathinones. Current Topics in Neurotoxicity. 12. Cham: Springer. 2018. pp. 125–152. doi:10.1007/978-3-319-78707-7_8. ISBN 978-3-319-78706-0. 
  3. "Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones". Drug Testing and Analysis 3 (9): 569–75. September 2011. doi:10.1002/dta.204. PMID 21960541. 
  4. "Toxicity and death following recreational use of 2-pyrrolidino valerophenone". Clinical Toxicology (Philadelphia, Pa.) 51 (9): 899–903. November 2013. doi:10.3109/15563650.2013.847187. PMID 24111554.